Coronavirus and the medicines supply chain

Coronavirus and the medicines supply chain

February 14, 2020

The Department of Health and Social Care (DHSC) has published a news story detailing its work to monitor the impact of the novel coronavirus – now named COVID-19 – on the medicine supply chain.

The Government made clear that, whilst there are currently no medicine shortages linked to the restrictions on movement in China, it is important to take precautionary steps now to help ensure the supply of medicines to UK patients remains uninterrupted.

Using communication routes that had been established to prepare for a possible no-deal Brexit, DHSC has contacted medicines manufacturers and suppliers to undertake risk assessments on the impact of COVID-19 on their business operations and, as a precaution, retain any existing stockpiles that were created ahead of the UK’s exit from the EU. As was the case previously, neither patients nor NHS providers are required to stockpile medicines themselves as this could lead to shortages for others.

The situation will continue to be monitored and additional measures may be introduced if and when necessary.

Guidance for healthcare professionals on COVID-19 can be found on the GOV.UK website.

Posted in: , ,

More Latest News >